ELEUSIS
Dead / Abandoned — Abandoned — failure to respond (as of 20 Jan 2023)
What this means for you
This application is over — abandoned 09 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90715197
- Mark type
- Stylized text
- Filed
- 17 May 2021
- Abandoned
- 09 Jan 2023
- Attorney of record
- Jeffrey J. Ellison
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of psychiatric disorders, neurological disorders, inflammatory disorders, and ocular indications
Owner
- Eleusis Therapeutics US, Inc., New York, NY, US
Prosecution history
- 20 Jan 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 20 Jan 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 20 Jan 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 08 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Jul 2022 — NON-FINAL ACTION E-MAILED
- 08 Jul 2022 — NON-FINAL ACTION WRITTEN
- 27 Jun 2022 — ASSIGNED TO EXAMINER
- 27 Jan 2022 — ASSIGNED TO EXAMINER
- 26 Jan 2022 — ASSIGNED TO EXAMINER
- 14 Aug 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED